Mary Ellen Hackett
Manager, Communications Office
Email maryellen.hackett@nih.gov or call 301-401-8670 for all media related questions.
Featured News
All News
Exosomes in personalized medicine for pancreatic cancer
Nature’s own delivery system meets precision oncology: the decade-long journey of engineered exosomes to a first-in-human KRAS trial.POSTED: 1/12/2026
Bioinformatics analyst recognized for potential enhancement to HER2 gene detection
A Molecular Characterization Laboratory bioinformatics analyst was recognized by the Association for Molecular Pathology for research showing blood-based sequencing can detect the HER2 biomarker as accurately as traditional assays that required a biopsy.POSTED: 1/8/2026
LZTR1: How it recognizes, binds, and degrades RAS proteins
New structures reveal how LZTR1 recognizes inactive RAS proteins for degradation, opening a new path to therapeutically eliminate oncogenic KRAS.POSTED: 12/15/2025
Biotech Connector reimagines the future of gene and cell-based therapies
Frederick’s biotech innovators discussed how they're revolutionizing gene and cell therapies through cutting-edge manufacturing, streamlined supply chains, and powerful automation.POSTED: 12/9/2025
Exploiting cellular degradation machinery as a potential treatment strategy for RAS-driven cancers
In a recent study, the Frederick National Laboratory team used the X-ray crystallography technique to reveal the atomic details of how LZTR1 interacts with different RAS family members, including RIT1, MRAS and KRAS.POSTED: 12/3/2025
Unpacking the diversity among KRAS mutants
From KRAS G12D to KRAS G12R, new research uncovers how each mutation drives pancreatic cancer differently—and why it matters for patient outcomes.POSTED: 11/19/2025
International study results show need for universal set of quality control materials for liquid biopsies
A partnership determined that quality control materials for liquid biopsies showed uneven results and performed differently depending on the assay platform used.POSTED: 11/18/2025
Dr. Denise Whitby’s three decades of research on Kaposi’s Sarcoma and HIV
A recognized global leader in the KSHV communityPOSTED: 11/13/2025
NIH establishes nation's first dedicated organoid development center to reduce reliance on animal modeling
The Standardized Organoid Modeling Center aims to produce standardized protocols for organoid research, addressing reproducibility challenges.POSTED: 9/25/2025